| Feature | Totipotent | Pluripotent | Multipotent |
|---|---|---|---|
| Range of cell types | All body + extra‑embryonic | All body cell types | Limited related cell types |
| Developmental stage | Zygote to early embryo | Inner cell mass of blastocyst | Adult tissues |
| Therapeutic potential | Broadest but ethically limited | High but regulated | Safest and widely used |
Totipotency vs pluripotency differs in the ability to form extra‑embryonic tissues, which is crucial for early embryo formation and is a key ethical boundary in stem cell research.
Pluripotent vs multipotent cells differ in flexibility; multipotent cells are restricted to producing cells within a specific tissue system, such as blood or neural cells.
Embryonic vs adult stem cells differ in potency and ethical considerations, influencing their use in therapies and research.
Define potencies precisely, noting which tissues each can form, as exam questions often test subtle distinctions between pluripotent and totipotent.
Relate potency to developmental stage, since many questions ask when each type of stem cell exists in the embryo.
Discuss ethical dimensions when asked, especially when comparing embryonic and adult stem cell sources, as ethical evaluation is a frequent exam theme.
Check whether cells can form extra‑embryonic tissues, a common point of confusion used in assessment questions.
Link stem cell use to medical applications, as exams expect clear reasoning about why potency affects therapeutic value.
Confusing totipotency and pluripotency, especially assuming both can form extra‑embryonic tissues; only totipotent cells can.
Assuming adult stem cells are rare but functionally equivalent, when in fact they have restricted potency compared to embryonic cells.
Believing differentiation is reversible, whereas gene expression patterns and epigenetic modifications usually make specialisation permanent.
Thinking all stem cells have equal therapeutic potential, when differences in potency affect which conditions they can treat.
Stem cells connect to gene expression because potency depends on which genes remain accessible for transcription during development.
Potency relates to epigenetics, as DNA methylation and histone modifications progressively limit developmental options. These processes explain why potency decreases over time.
Medical applications such as regenerative medicine rely on understanding how to manipulate potency and differentiation pathways.
Research in induced pluripotent stem cells (iPSCs) expands potential uses by reprogramming mature cells to a pluripotent state, linking developmental biology with genetic engineering.